3,5-diiodothyronine has been researched along with fluorescein in 1 studies
| Studies (3,5-diiodothyronine) | Trials (3,5-diiodothyronine) | Recent Studies (post-2010) (3,5-diiodothyronine) | Studies (fluorescein) | Trials (fluorescein) | Recent Studies (post-2010) (fluorescein) |
|---|---|---|---|---|---|
| 126 | 1 | 58 | 6,214 | 283 | 2,082 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canzoniero, LM; Del Viscovo, A; Esposito, A; Goglia, F; Moreno, M; Secondo, A | 1 |
1 other study(ies) available for 3,5-diiodothyronine and fluorescein
| Article | Year |
|---|---|
Intracellular and plasma membrane-initiated pathways involved in the [Ca2+]i elevations induced by iodothyronines (T3 and T2) in pituitary GH3 cells.
Topics: Calcium; Calcium Signaling; Carrier Proteins; Cell Membrane; Cells, Cultured; Diiodothyronines; Fluorescein; Fluorescent Dyes; Homeostasis; Humans; Inositol 1,4,5-Trisphosphate; Intracellular Membranes; Ion Channels; Mitochondria; Nitric Oxide; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pituitary Gland; Signal Transduction; Sodium; Transfection; Triiodothyronine | 2012 |